Journal profile · Statistics & Probability
Pharmaceutical Statistics
ISSN 1539-1604 · eISSN 1539-1612 · John Wiley and Sons Ltd · ENGLAND · Quarterly · Founded 2002
Pharmaceutical Statistics: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.51; hybrid open access; APC about USD 4,880; median 243 days to acceptance (93 articles, last 24 months); community-reported acceptance: easy; 90 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Pharmaceutical Statistics is published by John Wiley and Sons Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Statistical Methods in Clinical Trials, Optimal Experimental Design Methods and Advanced Causal Inference Techniques, together about 50% of its articles. Its main subfields are Statistics and Probability. (generated from OpenAlex topic counts and CAS ranking data)
Pharmaceutical Statistics is an industry-led initiative, tackling real problems in statistical applications. The Journal publishes papers that share experiences in the practical application of statistics within the pharmaceutical industry. It covers all aspects of pharmaceutical statistical applications from discovery, through pre-clinical development, clinical development, post-marketing surveillance, consumer health, production, epidemiology, and health economics. The Journal is both international and multidisciplinary. It includes high quality practical papers, case studies and review papers. The journal accepts high quality papers in the following formats: • Main Paper (Original Article) should be novel and share experiences in the practical application of statistics within the pharmaceutical industry. There is no formal limit on the word count. However, a lengthy manuscript might suggest that clarity of the presentation can be improved. If the word count exceeds 4,000 it is suggested to consider shortening or omitting selected sections. • Short Communications are short contributions that present original and significant material for rapid dissemination. Short Communications should not exceed 1,500 words. • Viewpoint: Viewpoint articles are short pieces that express the opinions of the authors. The ideal length of a viewpoint is 1,000-1,500 words. Viewpoint articles should focus on a particular subject and should not contain great technical detail. Papers that rely on technical arguments to support the authors’ positions or opinions should be submitted as main papers. • Tutorial: The aim of the tutorial section is to provide resources that effectively illustrate the application of current statistical practices and state-of-the art statistical methodology in drug development. Tutorials should include practical examples and reproducible code, thereby enabling readers to better understand and implement the presented statistical techniques in the drug development process. There is no formal limit on the word count. Ideas and proposal for tutorials can be submitted to the Tutorial section editor. • Case Studies. • Book Review. The aims of the Journal are to: 1. Disseminate information and practical examples of the full range of statistical methods and statistical thinking in all stages of drug development, from discovery to production; 2. Debate the current practice and application of statistics within the pharmaceutical industry and how this can best be de
From the journal's Aims & Scope
Research area (LetPub): Statistics & Probability
Editor-in-chief Olivier CollignonPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named United States 26, United Kingdom 10, Switzerland 7, Netherlands 3, France 2 (55 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Statistical Methods in Clinical TrialsMathematics29.8%
- Optimal Experimental Design MethodsDecision Sciences10.8%
- Advanced Causal Inference TechniquesMathematics9.5%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance8.8%
- Statistical Methods and Bayesian InferenceMathematics8.5%
- Statistical Methods and InferenceMathematics6.7%
- Meta-analysis and systematic reviewsDecision Sciences2.8%
- Computational Drug Discovery MethodsComputer Science2.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Statistics & Probability | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
| Minor | Statistics & Probability | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
| Minor | Statistics & Probability | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbaseCurrent ContentsPublisher website
Other: ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.51LetPub ·
- Impact factor (publisher)
- 1.5Publisher website ·
- Impact factor (publisher) 2025
- 1.5Publisher website ·
- CiteScore 2026-06
- 2.6LetPub ·
- CiteScore (publisher)
- 2.6Publisher website ·
- CiteScore (publisher) 2025
- 2.6Publisher website ·
- SJR 2026-06
- 0.99LetPub ·
- SNIP 2026-06
- 1.13LetPub ·
- h-index
- 33LetPub ·
- h-index
- 62OpenAlex ·
- i10-index
- 490OpenAlex ·
- 2-year mean citedness
- 1.58OpenAlex ·
- Self-citation rate
- 6.7%LetPub ·
- Share of gold OA articles
- 26.85%LetPub ·
Volume
- Articles per year
- 58LetPub ·
- Articles per year (publisher) 2025
- 73Publisher website ·
- Downloads per year (publisher) 2025
- 194,528Publisher website ·
Articles by year OpenAlex count · 1,811 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 70 | 39 | 7 |
| 2025 | 90 | 52 | 118 |
| 2024 | 111 | 68 | 303 |
| 2023 | 78 | 47 | 379 |
| 2022 | 102 | 36 | 588 |
| 2021 | 104 | 46 | 876 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
243 daysMedian, submission to acceptance · P25–P75 186 days – 339 days
- Acceptance to online
- median 20 days (94 articles)
- Submission to online
- median 266 days
- Sample
- 93 articles with submission and acceptance dates (167 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance rate (publisher)
- 31%Publisher website ·
- Acceptance rate (publisher) 2025
- 31%Publisher website ·
- Submission to first decision
- 47 daysPublisher website ·
- Submission to first decision 2025
- 47 daysPublisher website ·
- Submission to acceptance 2025
- 263 daysPublisher website ·
- Acceptance to publication 2025
- 26 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,880 / EUR 4,030 / GBP 3,240 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Manuscript length
- ≤ 4,000 words
- Reference style
- AMA
- First submission
- Free format: the journal's layout is not required
Article types accepted5, with length limits
- main papers (original articles)Main Papers (Original Articles) should be novel and share experiences in the practical application of statistics within the pharmaceutical industry. There is no…Length not stated
- short communicationicant material for rapid dissemination. Short Communications should not exceed 1,500 words. Viewpoint articles are short pieces that express the opinimain text ≤ 1,500 words
- short communicationsShort Communications are short contributions that present original and significant material for rapid dissemination. Short Communications should not exceed 1,50…Length not stated
- viewpoints of the authors. The ideal length of a viewpoint is 1,000-1,500 words. Viewpoint articles should focus on a particular subject anmain text ≤ 1,500 words
- viewpoint articlesViewpoint articles are short pieces that express the opinions of the authors. The ideal length of a viewpoint is 1,000-1,500 words. Viewpoint articles should fo…Length not stated
Policy excerpts from the journal's websitePublication ethics, License & copyright, Open access, Preprints
- Publication ethics Publication Ethics
Wiley's Best Practice Guidelines on Publishing Ethics are now available. The aim for these guidelines remains to support all those involved in scholarly publishing with a summary of best practice guidance from leading organizations around the world. Our guidelines are written for societies, editors, authors, librarians, students, funders, corporations, and journalists.Return to Top
Source ↗Publisher website ·- License & copyright Copyright and Permissions
To enable the publisher to disseminate the author's work to the fullest extent, the author must sign a license agreement transferring copyright in the article from the author to the publisher, and complete the agreement with the article presented for publication. Submission of a manuscript will be held to imply that it contains original unpublished work and is not being submitted for publication e…
Source ↗Publisher website ·- Open access Open Access
Open Access is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With Open Access, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon pub…
Source ↗Publisher website ·- Preprints Preprint Policy
Preprint policy Model summary
Pharmaceutical Statistics will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- John Wiley and Sons Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Quarterly
- Founded
- 2002
- ISSN
- 1539-1604
- Electronic ISSN
- 1539-1612
- Latest issue on the website
- Volume 25, Issue 6 (December 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Pharmaceutical Statistics
What CAS zone is Pharmaceutical Statistics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Pharmaceutical Statistics is in Zone 4 of Medicine, and in Zone 3 of the minor category Statistics & Probability / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Pharmaceutical Statistics?
The latest impact factor listed by LetPub is 1.51; CiteScore 2.6, h-index 62.
How long does peer review take at Pharmaceutical Statistics?
Based on the dates recorded on 93 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 243 days (interquartile range 186–339 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 31% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Pharmaceutical Statistics?
According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 4,000 words; Reference style: AMA; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Pharmaceutical Statistics based?
Of the 55 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United States (26), United Kingdom (10) and Switzerland (7). Counted from the institutions listed on the board page; for reference only.
Which databases index Pharmaceutical Statistics?
According to LetPub and DOAJ records, Pharmaceutical Statistics is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase and Current Contents; that list has not been checked against each database.
Is Pharmaceutical Statistics open access, and what is the APC?
Pharmaceutical Statistics is a hybrid journal. For open-access publication: APC about USD 4,880.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .